SCHEMBL6785117

SCHEMBL6785117

O=C(c1ccccc1OCc1ccccc1)N(Cc1ccccc1-c1ccccc1)c1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TSHR P16473 3/20 0.49
▸ SGMS2 Q8NHU3 1/20 0.47
▸ TRPM8 Q7Z2W7 1/20 0.47
▸ PTGER1 P34995 4/20 0.47
▸ PTGER4 P35408 4/20 0.47
▸ PTGER3 P43115 4/20 0.47
▸ PTGER2 P43116 4/20 0.47
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ HTT P42858 2/20 0.45
▸ ALOX15 P16050 1/20 0.45
▸ RXRA P19793 1/20 0.44
▸ RXRB P28702 1/20 0.44
▸ RXRG P48443 1/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ TP53 P04637 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6783823 0.89 ALDH1A1 (0.47) TSHRTRPM8SMN1; SMN2HTTALOX15
SCHEMBL6783999 0.85 PTGER1 (0.47) SGMS2TRPM8PTGER1PTGER4PTGER3
SCHEMBL6774393 0.82 TSHR (0.47) TSHRTRPM8SMN1; SMN2HTTALDH1A1
SCHEMBL6780398 0.79 LMNA (0.51) PTGER1PTGER4PTGER3PTGER2ALDH1A1
SCHEMBL6781601 0.79 TP53 (0.64) TSHRTRPM8SMN1; SMN2HTTALDH1A1
SCHEMBL6774110 0.78 SGMS2 (0.50) SGMS2TRPM8PTGER1PTGER4PTGER3
SCHEMBL6778429 0.74 MAPT (0.50) ALOX15ALDH1A1MAPK1KDM4EL3MBTL1
SCHEMBL6781088 0.72 ALDH1A1 (0.45) TSHRSGMS2HTTALDH1A1L3MBTL1
SCHEMBL6775891 0.72 PDK1 (0.47) TSHRSMN1; SMN2ALDH1A1KDM4EPOLB
SCHEMBL14610215 0.70 TRPM8 (0.52) TRPM8PTGER1PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US claimed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US claimed
US-6780883-B2 ANTICHOLESTEROL AGENTS; CARDIOVASCULAR DISORDERS; ANTILIPEMIC AGENTS; RESTENOSIS; DIETETICS WARNER-LAMBERT COMPANY 2004-08-24 — — US disclosed
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein BOOTH RICHARD JOHN (US) 2002-10-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020156281-A1 Amide inhibitors of microsomal triglyceride transfer protein CETP, MTTP, LCAT TSHR 1297/4885SGMS2 459/4885TRPM8 3581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback